» Articles » PMID: 27472372

A Review of the Multidisciplinary Diagnosis of Interstitial Lung Diseases: A Retrospective Analysis in a Single UK Specialist Centre

Overview
Journal J Clin Med
Specialty General Medicine
Date 2016 Jul 30
PMID 27472372
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The accurate diagnosis and management of individuals with interstitial lung diseases (ILDs) poses an interesting challenge in clinical practice. A multidisciplinary team (MDT) approach is considered the gold standard. This is a single-centre retrospective review spanning a five-year period. We assessed the accuracy of prior ILD diagnosis, the methodology used to establish a correct diagnosis and how an MDT approach affected subsequent management. Our data supports an MDT approach in an experienced specialist ILD centre. We have demonstrated that diagnosis is often changed after an MDT review and that this impacts the subsequent management. Our results demonstrate that an MDT approach to diagnosis can establish a diagnosis in the majority of cases when prior diagnosis is uncertain (76%). We also show that a prior diagnosis of idiopathic pulmonary fibrosis is deemed inaccurate in over 50% of cases after MDT discussion. We have shown that during diagnostic uncertainty the considered gold standard of proceeding to a lung biopsy is not always feasible due to disease severity and comorbidities. In these circumstances, an MDT approach to diagnosis of ILDs combines clinical data with serial lung function and disease behavior, with or without responses to previous treatment trials to establish an accurate expert diagnosis.

Citing Articles

ILDIM-MFAM: interstitial lung disease identification model with multi-modal fusion attention mechanism.

Zhong B, Zhang R, Luo S, Zheng J Front Med (Lausanne). 2024; 11:1446936.

PMID: 39624040 PMC: 11609931. DOI: 10.3389/fmed.2024.1446936.


Diagnosis and Management of Drug-Induced Interstitial Lung Disease in the context of Anti-Cancer Therapy: a Multidisciplinary Viewpoint by Portuguese Experts.

Fontes E Sousa M, Campainha S, Marques I, Dinis R, Inacio J, Mendes J Clin Drug Investig. 2024; 44(11):801-810.

PMID: 39500817 PMC: 11564330. DOI: 10.1007/s40261-024-01400-z.


Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives.

Cottin V, Martinez F, Smith V, Walsh S Eur Respir Rev. 2024; 31(165).

PMID: 38743511 PMC: 9724802. DOI: 10.1183/16000617.0003-2022.


The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases.

Sanduzzi Zamparelli S, Sanduzzi Zamparelli A, Bocchino M Diagnostics (Basel). 2023; 13(14).

PMID: 37510180 PMC: 10378270. DOI: 10.3390/diagnostics13142437.


[Interstitial Lung Disease].

Margallo Iribarnegaray J, Churruca Arrospide M, Matesanz Lopez C, Perez Rojo R Open Respir Arch. 2023; 5(2):100248.

PMID: 37496878 PMC: 10369608. DOI: 10.1016/j.opresp.2023.100248.


References
1.
Gribbin J, Hubbard R, Le Jeune I, Smith C, West J, Tata L . Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006; 61(11):980-5. PMC: 2121155. DOI: 10.1136/thx.2006.062836. View

2.
Thomeer M, Demedts M, Behr J, Buhl R, Costabel U, Flower C . Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J. 2007; 31(3):585-91. DOI: 10.1183/09031936.00063706. View

3.
Bradley B, Branley H, Egan J, Greaves M, Hansell D, Harrison N . Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63 Suppl 5:v1-58. DOI: 10.1136/thx.2008.101691. View

4.
. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161(2 Pt 1):646-64. DOI: 10.1164/ajrccm.161.2.ats3-00. View

5.
Wells A, Costabel U, Poletti V, Crestani B, Egan J, Margaritopoulos G . Challenges in IPF diagnosis, current management and future perspectives. Sarcoidosis Vasc Diffuse Lung Dis. 2015; 32 Suppl 1:28-35. View